New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls. Read the Q3 2026 report

Novartis AG

NVS

Healthcare Drug Manufacturers General

Novartis AG’s revenue for fiscal 2025 (year ended December 2025) was $56.7 billion, up 9.57% from fiscal 2024.

Revenue
+4.67%
EPS
−68.8%
Free cash flow
−17.8%
Total debt
+53.9%

Quarter to September 2026, against a year earlier

152.04 0.83 +0.55%
Market cap
$277.7B
P/E
28.8×
Fwd P/E FY26e
24.0×
Dividend yield
3.13%
F-score
8/9
ROIC
12.1%
Net debt / EBITDA
1.0×
Payout ratio
0.9×

What it owns vs. what it owes End of fiscal 2025, Dec 31, 2025

It owes $21.9B more in debt than it holds in cash and short-term investments. Debt has risen from $23.8B to $33.5B since FY16. Shareholders’ equity is 42.0% of the balance sheet. What is a balance sheet?

Dec 31, 2025 · total $110.9B

Owns

$80.5BLong-term assets
$18.9BOther short-term assets
$11.6BCash & short-term investments

Funded by

$46.5BShareholders’ equity
$30.9BOther liabilities
$33.5BDebt

Debt is 30.2% of the total; shareholders’ equity 42.0%.

Net debt rose from 12% of assets to 20% since FY16.

Total assetsNet debt (debt less cash)Net debt ÷ assets (right axis)
Assets and net debt, ten years
FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Total assets$130.1B$133.1B$145.6B$118.4B$127.8B$131.8B$117.5B$99.9B$102.2B$110.9B
Net debt (debt less cash)$16.0B$19.0B$16.2B$15.9B$24.5B$868M$7.2B$10.2B$16.1B$21.9B
Net debt ÷ assets (right axis)12.3%14.3%11.1%13.5%19.2%0.7%6.2%10.2%15.8%19.8%
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Total current assets
24,931.00 28,208.00 35,563.00 29,504.00 29,673.00 45,718.00 36,910.00 30,481.00 29,704.00 30,460.00
Total non-current assets
105,193.00 104,871.00 110,000.00 88,866.00 98,105.00 86,077.00 80,543.00 69,464.00 72,542.00 80,489.00
Total Assets
130,124.00 133,079.00 145,563.00 118,370.00 127,778.00 131,795.00 117,453.00 99,945.00 102,246.00 110,949.00
Total current liabilities
22,209.00 23,403.00 29,607.00 28,264.00 33,059.00 30,208.00 28,656.00 26,390.00 28,692.00 27,278.00
Total non-current liabilities
33,024.00 35,449.00 37,264.00 34,555.00 38,053.00 33,765.00 29,374.00 26,805.00 29,428.00 37,122.00
Total liabilities
55,233.00 58,852.00 66,871.00 62,819.00 71,112.00 63,973.00 58,030.00 53,195.00 58,120.00 64,400.00
Common Equity (Total)
74,891.00 74,227.00 78,692.00 55,551.00 56,666.00 67,822.00 59,423.00 46,750.00 44,126.00 46,549.00
Shareholders Equity (Total)
74,891.00 74,227.00 78,692.00 55,551.00 56,666.00 67,822.00 59,423.00 46,750.00 44,126.00 46,549.00
Total Debt
23,802.00 28,532.00 32,148.00 27,384.00 36,044.00 29,197.00 26,175.00 24,611.00 29,598.00 33,537.00

Show all line items

In millions of $ except per-share values · columns are period end dates · fundamentals updated Nov 18, 2026